PeerVoice Oncology & Haematology Audio

About PeerVoice Oncology & Haematology Audio

PeerVoice is committed to producing and distributing evidence-based, independently-created medical education in Oncology & Haematology that is designed to positively impact patient care. Activities can either be accredited or non-accredited but are always driven by the learning and practice needs of healthcare professionals. Learn more at: https://peervoice.com.

Publisher

PeerVoice

Category

education · health & fitness · science

Language

en

Explicit

No

First episode

28 Feb 2022

Latest episode

8 Oct 2026

Latest episodes

162 episodes in the feed.

1. 

   8 Oct 2026

   Laura Ruth Alder, MD / Puneeth Iyengar, MD, PhD / Pooja Karukonda, MD - Shifting the Status Quo in LS-SCLC: The Practicalities of Integrating Immunotherapy Into Treatment Pathways

   For the complete activity, including supporting material, please visit https://www.peervoice.com/ZCX860. Presented by Laura Ruth Alder, MD; Puneeth Iyengar, MD, PhD; and Pooja Karukonda, MD. Learning Objectives: Describe the clinical and radiographic criteria used to define limited-stage small cell lung cancer (LS-SCLC) and common pitfalls encountered in real-world practice; Summarize recent evidence and guideline changes in LS-SCLC management, including subgroup-specific considerations; Integrate patient response, treatment regimen, and multidisciplinary input to determine eligibility, timing, and duration of consolidation immunotherapy in real-world LS-SCLC care; Describe strategies for differentiating disease progression versus treatment-associated pneumonitis in patients receiving immunotherapy for LS-SCLC and implications for anti-cancer treatment decisions.

2. 

   22 Sept 2026

   Eileen M. O'Reilly, MD, FASCO - Hope Is on the Horizon: Anticipating Novel Treatment Approaches in Advanced Pancreatic Cancer

   For the complete activity, including supporting material, please visit https://www.peervoice.com/RAZ860. Presented by Eileen M. O'Reilly, MD, FASCO. Learning Objectives: Recognise patient-reported burdens associated with the diagnosis of advanced pancreatic cancer and how these impact decisions surrounding treatment; Identify therapeutic agents under investigation for the management of advanced pancreatic cancer and their current state of development; Implement current, evidence-based best practices in the management of advanced pancreatic cancer, including providing appropriate mental health support to patients.

3. 

   4 Sept 2026

   Eric Van Cutsem, MD, PhD - Biology that Transcends Tumour Type: Integrating Tumour-Agnostic With Tumour-Specific Treatments for HER2-Positive Gastrointestinal Cancers

   Eric Van Cutsem, MD, PhD, discusses integrating tumour-agnostic and tumour-specific treatments for HER2-positive gastrointestinal cancers, offering insights into biomarker-targeted therapies.

Who has been a guest on PeerVoice Oncology & Haematology Audio

Names identified in recent episode analyses. Showing up to five guests.

• Eric Van Cutsem
• Florian Lordick
• Lorenza Rimassa
• Giannis Mountzios
• Jeffrey Weitz

Reach and audience

Public platform figures. Ratings count people who left a rating, not total listeners.

Apple Podcasts (US)

5.0 / 5

2 ratings

Spotify

5.0 / 5

1 ratings

Contact PeerVoice Oncology & Haematology Audio

Guest appearances

Books guests

Based on episode analysis; this does not confirm that the show is currently accepting guests.